Compound Library

Peptide / Metabolic

AOD-9604

GH fragment (amino acids 176–191) retaining fat-burning but not anabolic properties. No IGF-1 elevation. Failed Phase 3 FDA approval but widely used in body composition research. Best taken fasted.

Build protocol outline Open dose calculator TNHL ebooks
Educational reference only. This page does not diagnose, prescribe, or replace care from a licensed professional. Laws, availability, and clinical appropriateness vary by location.
Reference dose250–500 mcg SubQ fasted morning or pre-workout
Half-life0.5 hours
Risk flaglow
Regulatory noteResearch-only flag

Side effects and watch-outs

  • Mild injection site redness
  • Headache at high doses
  • Nausea (uncommon)
  • Generally well tolerated — no IGF-1 or organomegaly concerns